세계의 색전용 입자 시장 : 시장 규모(부문별), 점유율, 규제, 상환, 개입, 예측(-2036년)

Embolization Particles Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036

US $ 7,500 ￦ 10,809,000

Excel (Single User License)

Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 15,000 ￦ 21,619,000

Excel (Site License)

Excel 보고서를 동일 기업의 한 부서에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 22,500 ￦ 32,429,000

Excel (Global License)

Excel 보고서를 동일 기업(해외)의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

색전용 입자 시장은 고령화, 간암, 신세포암, 신장암, 신경내분비종양, 동정맥기형, 자궁근종, 전립선 비대증 환자 증가 등 다양한 요인에 의해 주도되고 있습니다.

세계의 색전용 입자 시장에 대해 조사 분석했으며, 각 지역별 시장 규모, 주요 동향, 혁신적인 제품 및 기술, 경쟁 구도 등의 정보를 전해드립니다.

시장 모델의 주요 내용은 다음과 같습니다.

시판 중인 색전용 입자와 진화하는 경쟁 상황

• 주요 산업 동향 인사이트
• 색전용 입자 시장의 각 부문별 연간 매출 및 시장 전망(2015-2036년)
• 부문별 총 개입 건수, 유닛 수, 평균 판매 가격, 시장 금액에 대한 상세 데이터

세계, 지역, 국가 단위의 각 시장 인사이트

• 세계 동향을 지역별로 분류한 정성적인 각 시장 정보 및 각국 시장 인사이트
• 색전용 입자 시장의 SWOT 분석
• 색전용 입자 시장의 경쟁 역학에 대한 인사이트와 동향

의료제도의 개요를 포함한 진정한 전체상을 파악함으로써 시장의 이해를 촉진합니다. 또한, 시장 진입 부문에서는 상환 정책 및 규제 상황에 대한 정보를 제공하고 시장 역학에 대해 더 깊이 있게 살펴볼 수 있습니다.

• 각국의 의료제도 개요
• 각국의 상환 정책
• 각국의 의료기술 관련 규제 현황

대상 기업

• Boston Scientific Corp
• Merit Medical Systems Inc
• Sirtex Medical Ltd
• Terumo Corp
• Wilson-Cook Medical Inc
• Varian Medical Systems Inc
• Others

KSM

영문 목차

영문목차

Embolization Particles Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 is built to visualize quantitative and qualitative market trends within General Surgery Devices therapeutic area.

Embolization is a procedure that uses particles such as tiny gelatin sponges or beads to block a blood vessel. Embolization Particles are used to stop bleeding or are used to block the flow of blood to a tumor. Embolization Particles are generally used to treat liver cancer, renal cell carcinoma, kidney cancer, neuroendocrine tumors, arteriovenous malformation, uterine fibroids and benign prostatic hyperplasia. Embolization particles can be categorized into four segments based on composition and mechanism of action: Polyvinyl Alcohol (PVA) Particles, Microspheres, Drug-Eluting Beads, Radioembolization Particles.

The embolization particles market is driven by a wide variety of factors including aging population, growing number of patients with liver cancer, renal cell carcinoma, kidney cancer, neuroendocrine tumors, arteriovenous malformation, uterine fibroids and benign prostatic hyperplasia.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with Intervention volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Embolization Particles and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Embolization Particles market revenue by segment and market outlooks from 2015-2036.
• Granular data on total Interventions, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Embolization Particles market.
• Competitive dynamics insights and trends provided for Embolization Particles market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Boston Scientific Corp, Merit Medical Systems Inc, Sirtex Medical Ltd, Terumo Corp, Wilson-Cook Medical Inc, Varian Medical Systems Inc, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Embolization Particles marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Embolization Particles market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Embolization Particles market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Embolization Particles market from 2015-2036.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

관련자료